Add to ORKGThis is a review describing advances in CRISPR/Cas-mediated therapies for neuromuscular disorders (NMDs). We explore both CRISPR-mediated editing and dead Cas approaches as potential therapeutic strategies for multiple NMDs. Last, therapeutic considerations, including delivery and off-target effects, are also discussed
This review discusses current bottlenecks in making CRISPR-Cas9-mediated genome editing a therapeuti...
Neuromuscular diseases are a broad group of debilitating disorders that impair muscle functioning. D...
The CRISPR-Cas9 gene editing system gives researchers the ability to manipulate and edit DNA with un...
This is a review describing advances in CRISPR/Cas-mediated therapies for neuromuscular disorders (N...
This is a review describing advances in CRISPR/Cas-mediated therapies for neuromuscular disorders (N...
IntroductionThe system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRI...
IntroductionThe system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRI...
Over the past few decades, as gene discovery methods and sequencing technologies have evolved, many ...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Number of CRISPR publications: A. per year; B. per disease type. Abbreviations: DMD–Duchenne’s muscu...
Neurodegenerative diseases (NDs) are a heterogeneous group of disorders affecting the central nervou...
This review discusses current bottlenecks in making CRISPR-Cas9-mediated genome editing a therapeuti...
Neuromuscular diseases are a broad group of debilitating disorders that impair muscle functioning. D...
The CRISPR-Cas9 gene editing system gives researchers the ability to manipulate and edit DNA with un...
This is a review describing advances in CRISPR/Cas-mediated therapies for neuromuscular disorders (N...
This is a review describing advances in CRISPR/Cas-mediated therapies for neuromuscular disorders (N...
IntroductionThe system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRI...
IntroductionThe system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRI...
Over the past few decades, as gene discovery methods and sequencing technologies have evolved, many ...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CR...
Number of CRISPR publications: A. per year; B. per disease type. Abbreviations: DMD–Duchenne’s muscu...
Neurodegenerative diseases (NDs) are a heterogeneous group of disorders affecting the central nervou...
This review discusses current bottlenecks in making CRISPR-Cas9-mediated genome editing a therapeuti...
Neuromuscular diseases are a broad group of debilitating disorders that impair muscle functioning. D...
The CRISPR-Cas9 gene editing system gives researchers the ability to manipulate and edit DNA with un...